Eli Lilly and NVIDIA have announced a major partnership with a total investment of $1 billion. The companies are establishing a joint R&D center...

The Russian healthcare regulator has summarized the results of its internet monitoring efforts. Last year, Roszdravnadzor identified thousands of violators and referred the data...

2026 marks not just the arrival of new therapies, but a fundamental shift in pharmaceutical manufacturing supply chains. The commercialization of oral obesity treatments...

OpenAI has officially announced its expansion into the healthcare sector with the launch of a dedicated product line. The company introduced the consumer-facing ChatGPT...

Far Eastern Federal University (FEFU) has announced plans to establish a comprehensive infrastructure for the development and commercialization of biotech products.

The days of "silence" in B2B pharma are over. A decade ago, manufacturing plants could operate quietly for years, relying solely on the personal networks of their commercial directors. Today, such a strategy is a brake on growth.